Long-Term Oncologic Outcomes of Endoscopic Management of High-Risk Upper Tract Urothelial Carcinoma: The Fundació Puigvert's Experience
Journal of Endourology · 2023
DOI: 10.1089/end.2023.0092 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Endourology, 2023. Verfasst von Michael Baboudjian und 15 weiteren Autor:innen. Beteiligte Einrichtung: Department of Urology, Fundació Puigvert, Autonoma University of Barcelona, Barcelona, Spain. Hauptthemen laut MEDLINE: Carcinoma, Transitional Cell, Urinary Bladder Neoplasms, Ureteral Neoplasms, Kidney Neoplasms. Die Arbeit wurde bisher 20-mal zitiert (Crossref) und nennt 12 Literaturangaben.
Abstract (Originalsprache)
Objectives
Many patients with upper tract urothelial carcinoma (UTUC) outside of the low-risk criteria may possess low absolute risks of distant progression. Herein, we hypothesized that careful selection of high-risk patients undergoing an endoscopic approach could result in acceptable oncologic outcomes. Materials and Methods: Patients with high-risk UTUC managed endoscopically between 2015 and 2021 were retrospectively identified from a prospectively maintained single academic institution database. Elective and imperative indications for endoscopic treatment were considered. Regarding elective indications, the decision to perform endoscopic treatment was systematically proposed to high-risk patients in whom macroscopically complete ablation was deemed feasible, excluding invasive appearance on CT scan, and without histologic variant.
Results
A total of 60 patients with high-risk UTUC met our inclusion criteria (29 imperative and 31 elective indications). The median follow-up in patients without any event was 36 months. At 5 years, the estimated overall survival, cancer-specific survival, metastasis-free survival, UTUC recurrence-free survival, radical nephroureterectomy-free survival, and bladder recurrence-free survival were 57% (41–79), 75% (57–99), 86% (71–100), 56% (40–76), 81% (70–93), and 69% (54–88), respectively. All oncologic outcomes were similar between patients with elective and imperative indications (all log-rank p > 0.05).
Conclusions
In conclusion, we report the first large series of endoscopic treatment in patients with high-risk UTUC, arguing that promising oncologic outcomes can be achieved in properly selected candidates. We encourage multi-institutional collaborative work as a large cohort of high-risk patients treated endoscopically may allow subgroup analyses to define the best candidates.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Urology, Fundació Puigvert, Autonoma University of Barcelona, Barcelona, Spain.
- Department of Urology, APHM, North Academic Hospital, Marseille, France.
- Department of Urology, IRCCS San Raffaele Hospital, Vita-Salute San Raffaele University, Milan, Italy.
- Department of Pathology, Fundació Puigvert, Autonomous University of Barcelona, Barcelona, Spain.
ORCID-Profile: Andrea Gallioli, Paolo Verri
Zitieren
APA
Baboudjian, M., Territo, A., Gallioli, A., Verri, P., Aumatell, J., Izquierdo, P., Uleri, A., Tedde, A., Basile, G., Gaya, J. M., Huguet, J., Rodriguez-Faba, O., Sanguedolce, F., Algaba, F., Palou, J., & Breda, A. (2023). Long-Term Oncologic Outcomes of Endoscopic Management of High-Risk Upper Tract Urothelial Carcinoma: The Fundació Puigvert's Experience. Journal of Endourology. https://doi.org/10.1089/end.2023.0092
Vancouver
Baboudjian M, Territo A, Gallioli A, Verri P, Aumatell J, Izquierdo P, et al. Long-Term Oncologic Outcomes of Endoscopic Management of High-Risk Upper Tract Urothelial Carcinoma: The Fundació Puigvert's Experience. Journal of Endourology. 2023. doi:10.1089/end.2023.0092
BibTeX
@article{Baboudjian2023,
author = {Baboudjian, Michael and Territo, Angelo and Gallioli, Andrea and Verri, Paolo and Aumatell, Julia and Izquierdo, Paula and Uleri, Alessandro and Tedde, Alessandro and Basile, Giuseppe and Gaya, Josep Maria and Huguet, Jorge and Rodriguez-Faba, Oscar and Sanguedolce, Francesco and Algaba, Ferran and Palou, Joan and Breda, Alberto},
title = {Long-Term Oncologic Outcomes of Endoscopic Management of High-Risk Upper Tract Urothelial Carcinoma: The Fundació Puigvert's Experience},
journal = {Journal of Endourology},
year = {2023},
doi = {10.1089/end.2023.0092}
}
EUVIMED